Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
Orlando Orthopaedic Center, Orlando, Florida, United States
Regina Elena CI, Rome, Italy
Women's College Hospital, Toronto, Ontario, Canada
Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of
Kuopio University hospital, Kuopio, Finland
Royal Adelaide Hospital, Adelaide, South Australia, Australia
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Riley Hospital for Children, Indianapolis, Indiana, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.